Consortium Consortium
 Euripides Europe Consortium

QuicklinksQuicklinks
Objectives Objectives
The Project The Project
Impact Impact


LoginMembers
Login Login


SEVENTH FRAMEWORK PROGRAMME
The Group - Consortium - Ludwig-Maximillians-Universitaet Muenchen

Ludwig-Maximilians-Universität
Koeniginstr. 16
80539 Munich

Germany

 Homepage



Project Leader


Prof. Dr. Heidrun Potschka Prof. Dr. Heidrun Potschka
Workpackage leader 
Phone: +49-(0)89-2180-2662 
Fax: +49-(0)89-2180-16556 
E-Mail to Prof. Dr. Heidrun Potschka Contact  
 

Prof. Dr. Peter Bartenstein
Head of the Clinic for Nuclear Medicine 
Phone: +49-(0)89-7095-4610 
Fax: +49-(0)89-7095-4648 
E-Mail to Prof. Dr. Peter Bartenstein Contact  
 



Project Staff


Mr. Hero Bartmann
Scientist (epilepsy models) 
Phone: +49-(0)89-2180-3873 
E-Mail to Mr. Hero Bartmann Contact  

Dr. rer. nat. Guido Boening
Project management (PET acquisition) – radiation safety 
Phone: +49-(0)89- 7095-4657 
E-Mail to Dr. rer. nat. Guido Boening Contact  

PhD Paul Cumming
Project management (PET modelling) 
Phone: +49-(0)89- 7095-4646 
E-Mail to PhD Paul Cumming Contact  

Christina Fuest
Project management (epilepsy models) and coordination 
Phone: +49-(0)89-2180-3264 
E-Mail to Christina Fuest Contact  

Dipl. Chem. Dr. rer. medic. Franz-Josef Gildehaus
Radiochemistry – animal care officer 
Phone: +49-(0)89- 7095-4645 
E-Mail to Dipl. Chem. Dr. rer. medic. Franz-Josef Gildehaus Contact  

Dr. Christian La Fougere
Project management (PET) – coordination  
Phone: +49-(0)89- 7095-4646 
E-Mail to Dr. Christian La Fougere Contact  

Mr. Sebastian Nowak
PET scan acquisition 
Phone: +49-(0)89- 7095-7617 
E-Mail to Mr. Sebastian Nowak Contact  

PhD Dr. Anton Pekcec
Project management (epilepsy models) 
Phone: +49-(0)89-2180-3264 
E-Mail to PhD Dr. Anton Pekcec Contact  

Dipl. Chem. Dr. rer. nat. Bjoern Waengler
Project management (radiochemistry) 
Phone: +49-(0)89- 7095-4657 
E-Mail to Dipl. Chem. Dr. rer. nat. Bjoern Waengler Contact  

Dipl. Biol. Erika Wagner
Scientist – animal handling 
Phone: +49-(0)89- 7095-4615 
E-Mail to Dipl. Biol. Erika Wagner Contact  


Institute Presentation


The University of Munich has recently been selected as one the centers of excellence amongst German universities, the only one with a focus on neuroscience. With the Graduate School of Systemic Neurosciences (GSN-LMU) the University offers an excellent educational platform with Master- and PhD programs in systemic neurosciences. Moreover a strong network exists at the University of Munich which links a variety of groups and disciplines related to questions of neurosciences thereby rendering a perfect basis for progress in the understanding of brain function.

In the Clinic for Nuclear Medicine of the Medical Faculty profound experience exists in radioligand synthesis and preclinical evaluation of radiopharmaceuticals including cell binding studies and autoradiography, PET imaging of receptor-ligand interaction including modeling and various voxel-wise quantification approaches in humans and rodents. The assessment of the action of various psychotropic drugs with PET has been another focus. The basic science oriented methodology group is embedded in Germanys largest clinical Nuclear medicine department equipped with PET-CT, 2 dedicated PET-cameras, suitable for neuro-imaging and several 2 and 3 headed SPECT-cameras and has facilities for radiotracer synthesis, cell culture and an animal PET-camera.

In the Institute of Pharmacology, Toxicology, and Pharmacy of the Faculty of Veterinary Medicine profound expertise exists in a variety of epilepsy models, and in neuropharmacological studies. Research during the last years contributed significantly to the characterization of multidrug transporters including their substrate specificity, their modulation, expression regulation, and contribution to pharmacoresistance of epilepsy. The group currently develops different innovative approaches to overcome transporter-mediated pharmacoresistance. Recent studies of the group elucidated the signaling pathways involved in the regulation of the multidrug transporter P-glycoprotein in capillary endothelial cells of the epileptic brain. Based on these data new targets for prevention of pharmacoresistance have been suggested. Different chronic epilepsy models are established in the institute including models with spontaneous seizures. A unique digital video-EEG monitoring unit allows simultaneous recordings from 16 animals and renders the basis for efficient pharmacological testing in these models. Thereby, established protocols which allow the selection of pharmacoresistant animals render the tool for proof-of-principle studies of radioligands within the consortium. Moreover, the strong background in immunohistochemistry and the excellent equipment for optical imaging (e.g. incl. confocal laser scanning microscopy, Microbrightfield system for unbiased stereology) allows the precise determination of the expression of transporters and other molecules of interest.

 


Ludwig-Maximillians-Universitaet Muenchen